Mamta Parikh, MD, MS
Mamta Parikh, MD, MS
@mamtaparikh.bsky.social
Genitourinary Oncologist at UCD Comprehensive Cancer Center, views/posts my own
Reposted by Mamta Parikh, MD, MS
Prior auth (PA) isn't just a hassle for providers. In a study of pts w/ cancer with treatment requiring PA, half reported direct involvement by themselves or a family member in obtaining their most recent PA. Data to be presented at the 2025 ASCO Quality Care Symposium www.asco.org/about-asco/p...
Prior Authorization Often Places Burden on Patients With Cancer, Delays Care - ASCO
According to a new study, three out of four people with cancer surveyed had to go through at least one recent prior authorization between 2022 and 2024. In half of those cases, patients and families w...
www.asco.org
October 7, 2025 at 12:15 AM
Reposted by Mamta Parikh, MD, MS
“American institutions and the innovators within them have succeeded based on a contract between the federal government and U.S. research universities. The result of major funding for research created the country we know today”

www.statnews.com/2025/06/06/u...
We set out to quantify U.S. academic contributions to medicines. The results stunned even us
From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.
www.statnews.com
June 9, 2025 at 1:09 PM
Reposted by Mamta Parikh, MD, MS
A pie graph worth keeping in mind as the NIH budget plummets jamanetwork.com/journals/jam... for 356 new FDA drugs approved
March 23, 2025 at 4:17 PM